Literature DB >> 15854074

Microbiological analysis of chronic dacryocystitis.

Xuguang Sun1, Qingfeng Liang, Shiyun Luo, Zhiqun Wang, Ran Li, Xiuying Jin.   

Abstract

AIMS: To investigate the microbiology of specimens from patients with chronic dacryocystitis.
METHODS: A total of 100 samples were obtained from the contents of the lacrimal duct in 91 consecutive patients with chronic dacryocystitis, including nine bilateral cases. These samples were cultured for aerobic and anaerobic bacteria and fungi with a routine microbiological technique. Positive cultured isolates were identified.
RESULTS: A total of 180 strains were isolated from the 85 bacterial samples, including 150 strains of aerobic bacteria and 30 strains of anaerobic bacteria. Fungi were found in eight samples and actinomyces in three samples. The bacterial species that were most frequently found were Staphylococcus species, representing 34.5% of all strains, followed by Corynebacterium diphtheroides (15.5%). The sensitivity tests revealed that levo-ofloxacin and amikacin were the most effective antibiotics.
CONCLUSIONS: Gram positive cocci was the predominant pathogen of chronic dacryocystitis. Levo-ofloxacin and amikacin had the best effect in vitro.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15854074     DOI: 10.1111/j.1475-1313.2005.00284.x

Source DB:  PubMed          Journal:  Ophthalmic Physiol Opt        ISSN: 0275-5408            Impact factor:   3.117


  12 in total

1.  Dacryocystitis: Systematic Approach to Diagnosis and Therapy.

Authors:  Sergio Pinar-Sueiro; Mercedes Sota; Telmo-Xabier Lerchundi; Ane Gibelalde; Bárbara Berasategui; Begoña Vilar; Jose Luis Hernandez
Journal:  Curr Infect Dis Rep       Date:  2012-01-29       Impact factor: 3.725

2.  Microbiologic spectrum of acute and chronic dacryocystitis.

Authors:  Bahram Eshraghi; Parisa Abdi; Mohammadreza Akbari; Masoud Aghsaei Fard
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

3.  A silastic sheet found during endoscopic transnasal dacryocystorhinostomy for acute dacryocystitis.

Authors:  Jin Seok Choi; Jong Hyeok Lee; Hae Jung Paik
Journal:  Korean J Ophthalmol       Date:  2006-03

4.  The microbiological profile of lacrimal abscess: two decades of experience from a tertiary eye care center.

Authors:  Mohammad Javed Ali; Swapna R Motukupally; Surbhi D Joshi; Milind N Naik
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-07-27

5.  Bacteriological profile and drug susceptibility patterns in dacryocystitis patients attending Gondar University Teaching Hospital, Northwest Ethiopia.

Authors:  Yared Assefa; Feleke Moges; Mengistu Endris; Banchamlak Zereay; Bemnet Amare; Damtew Bekele; Solomon Tesfaye; Andargachew Mulu; Yeshambel Belyhun
Journal:  BMC Ophthalmol       Date:  2015-04-02       Impact factor: 2.209

6.  Lacrimal Duct Occlusion Is Associated with Infectious Keratitis.

Authors:  Guigang Li; Jingmin Guo; Rong Liu; Weikun Hu; Lingjuan Xu; Juan Wang; Subo Cai; Hong Zhang; Yingting Zhu
Journal:  Int J Med Sci       Date:  2016-10-17       Impact factor: 3.738

7.  Conjunctival bacterial flora in fellow eyes of patients with unilateral nasolacrimal duct obstruction and its changes after successful dacryocystorhinostomy surgery.

Authors:  Bahram Eshraghi; Sayyed Amirpooya Alemzadeh; Zohreh Abedinifar
Journal:  J Curr Ophthalmol       Date:  2016-12-03

8.  Frequency of Bacterial Samples from Patients with Chronic Acquired Nasolacrimal Duct Obstruction.

Authors:  Kourosh Shahraki; Ali Makateb; Keyvan Shirzadi; Keivan Khosravifard
Journal:  Med Arch       Date:  2016-12

9.  Microbiology of primary acquired nasolacrimal duct obstruction: simple epiphora, acute dacryocystitis, and chronic dacryocystitis.

Authors:  Kanograt Pornpanich; Panitee Luemsamran; Amornrut Leelaporn; Jiraporn Santisuk; Nattaporn Tesavibul; Buntitar Lertsuwanroj; Sumalee Vangveeravong
Journal:  Clin Ophthalmol       Date:  2016-02-22

10.  Bacterial Flora of the Conjunctiva One Year after Dacryocystorhinostomy.

Authors:  Naser Owji; Alireza Zareifard
Journal:  Middle East Afr J Ophthalmol       Date:  2018 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.